References
- Okeahialam, B. N., Thacher, T. D, Ibrahim, T. M. and Anjorin, F. I. (1999). An open evaluation of lacidipine in the treatment of hypertension in Nigerian Africans. In AFPON 2nd AGSM Book of Abstracts, p. 13.
- Cbaignon, M. M. (1995). The dinical efficacy of lacidipine in hypertension Rev. Contemp. Phartnacother., 6, 17–27.
- Salako, B. L., Kadiri, S, Walker, O. and Fehintola, F. A. (1998). Evaluation of lacidipine (a calcium blacker) in the treatment of hypertension in black African people: a double blind comparison with hydrochlorothiazide.Afr J. Med. Med Sci., 27, 73–75.
- Okeahialarn, B. N., Isamade, I., Ibrahim, T. M. and Anjorin, F. I. (1998). The effect of lacidipine on patients with mild to moderate hypertension and the effect of a combination of lacidipine and hydrochlorothiazide in the treatment of hypertension uncontrolled after four weeks of lacidipine treatment: an open study. West Afr 1 Med., 17, 42–46.
- McMahon, S., Peto, R., Cutler, J., Coffins, R, Sortie, R, Neaton, J., Abbot, R., Godwin, J., Dyer, A. and Stamler, J. (1990). Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet, 335, 765–774.
- Collins, R, Peto, R, MacIVIahon, S., Hebert, P., Fiebach, N. H., Eberlein, K. A., Godwin, J., Qizlbash, N., Taylor, J. O. and Hennekens, C. H. (1990). Blood pressure, stroke and coronary heart disease; Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet, 335, 827–838.
- Opadijo, O. G. (1997). Biochemical and metabolic effects of short-term thiazide diuretic therapy in mild to moderate hypertension. Niger. Med. Pract., 33, 58–61.
- Klauser, R., Prager, R., Gaube, S., Gisinger, C., Schnack, C., Kuenburg, E. and Schernthaner, G. (1991). Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus. Hypertension, 17, 15–21.
- Wolledge, S. M., Carstairs, K. C. and Dade, J. V. (1966). Auto-immune haemolytic anaemia associated with methyl dopa therapy. Lancet, 1966; 2, 135–139.
- Oparil, S. (1993). Antihypertensive therapy - efficacy and quality of life (Editorial). N. Engl. 1 Med., 328, 959–961.
- Materson, B. J., Reda, D. J., Cushman, W. C, Massie, B. M., Freis, E. D., Kochar, M. S., Hamburger, R. J., Fye, C., Lakshman, R., Gottdiener, J., Ramutrez, E. A. and Henderson, W. G. (1993). Single dose therapy for hypertensive men. A comparison of six antihypertensive agents with placebo. N. Engl. J. Med., 328, 914–921.
- Kaplan, N. M. (1994). Treatment of hypertension: drug therapy. In Kaplan, N. M. (ed.) Clinical Hypertension, 6th edn, Williams and Wilkins, Baltimore, pp. 191–280.
- Cappuccio, F. P., Markundu, N. D., Singar, D. R., Bucldey, M. G., Miller, M. A., Sagnella, G. A. and MacGregor, G. A. (1991).A double blind cross over study of the effect of concomitant diuretic therapy in hypertensive patients treated with amlodipine. Am. J. Hypertens., 4, 297–302.
- Burns, J. F., Weir, M., Oparil, S., Webar, M., Cady, W. I. and Stewart, W. H. (1990). An assessmentofdilliazemandhydrochlorothiazide in hypertension. Application of factorial trial design in a multicentre clinical trial of combination therapy. J. Am. Med. Assoc., 263, 1507–1512.
- Isah, A. O., Obasohan, A. O. and Okpako, L. O. (1992). Open evaluation of amlodipine in Nigerian patients. Curr Ther. Res., 52, 812–818.
- Luschier, T. F. and Cosentino, F. (1998). The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal. Drug, 55, 509.
- Reuter, M. K., Lorenz, H., Verho, P., Smith, D., Degen, A. and Verho, M. (1998). Effects of felodipine ER, a dihypropyridine calcium antagonist on blood pressure and serum lipids. Curr. Med. Res. Opin., 14, 97–103.
- Gifford, R. W. (1997). Antihypertensive therapy: angiotensin converting enzyme inhibitor angiotension II receptor antagonist and calcium antagonists. Med. Clin. N. Am., 81, 1319–1333.
- Lardinois, C. K. and Neuman, S. L. (1988). The effects of antihypertensive agents on serum lipids and lipoproteins. Arch. Intern. Med., 148, 1280–1288.
- Sowers, J. R. (1997). Effects of calcium antagonists on insulin sensitivity and other metabolic parameters. Am. J. Cordial., 79, 24-28, 47–48.